http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3847375

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 96
issn 1365-2249
0009-9104
issueIdentifier 1
pageRange 89-96
publicationName Clinical and Experimental Immunology
startingPage 89
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5fbf80fc368bea2229dd4e819b646236
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_23d15f2d4e283bd608c3b7225379352a
bibliographicCitation Cruz CR, Lam S, Hanley PJ, Bear AS, Langston C, Cohen AJ, Liu H, Martinez CA, Krance RA, Heslop HE, Rooney CM, Hanson IC, Bollard CM. Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy. Clin Exp Immunol. 2013 Oct;174(1):89–96. PMID: 23763437; PMCID: PMC3784216.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5ca229b4664c1462dffbe3b7619371b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77e23483a49e5e5da850d1e27f9453b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56cb519bb6e562e988cdb0bc484926cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3a605a9073b3fbcbde25d316caf8d47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3781fdede20a38377a134ac71388d35b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3861408b98292a1007ea68f16180ec61
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8af1e2975d63db32637409bd138bc792
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71623e5fb73954f885c6978c8cd5a795
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d48069ddd1846e617c624c79925ce182
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c40753ef2a574b9675df41c1b88e21f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e367e58fbf8eaa8de51437bf8e499adc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daa2fae74efbc7595d2e21c4be4a6802
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd19927919df1eb701a12b7443aad666
date 2013-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/23763437
https://pubmed.ncbi.nlm.nih.gov/PMC3784216
https://doi.org/10.1111/cei.12156
isPartOf https://portal.issn.org/resource/ISSN/1365-2249
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3002
https://portal.issn.org/resource/ISSN/0009-9104
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy
discusses http://id.nlm.nih.gov/mesh/M0013336
http://id.nlm.nih.gov/mesh/M000627303
http://id.nlm.nih.gov/mesh/M0028676
http://id.nlm.nih.gov/mesh/M0471751
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013601Q000382
http://id.nlm.nih.gov/mesh/D016219Q000379
http://id.nlm.nih.gov/mesh/D006105Q000276
http://id.nlm.nih.gov/mesh/D006105Q000628
http://id.nlm.nih.gov/mesh/D013601Q000276
http://id.nlm.nih.gov/mesh/D001229Q000276
http://id.nlm.nih.gov/mesh/D001229Q000628
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008810
http://id.nlm.nih.gov/mesh/D002478
http://id.nlm.nih.gov/mesh/D018417Q000276
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019255Q000172
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008562Q000235
http://id.nlm.nih.gov/mesh/D019255Q000235
http://id.nlm.nih.gov/mesh/D002460
http://id.nlm.nih.gov/mesh/D018345
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D013601Q000473
http://id.nlm.nih.gov/mesh/D000074662
http://id.nlm.nih.gov/mesh/D001232Q000276
http://id.nlm.nih.gov/mesh/D008562Q000172
http://id.nlm.nih.gov/mesh/D018417Q000637
http://id.nlm.nih.gov/mesh/D018417Q000382
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11134
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7881
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8362
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6979

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13058

Total number of triples: 70.